{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-039111","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2024-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.300639+00:00","generated_at":"2026-05-30T22:41:46.870204+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Serina Therapeutics presents at Injectables Summit with Enable on SER-252 for Parkinson's","bullets":["Serina's CDO Randall Moreadith presents at 14th Annual Injectables Summit in Boston on October 2, 2024.","Joint presentation with Enable Injections' CCO Matthew Huddleston focuses on SER-252 for advanced Parkinson's disease.","Partnership combines Serina's SER-252 with Enable's enFuse wearable drug delivery platform.","No financial results, guidance, or other material corporate updates were provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-039111","json":"https://secwatch.observer/filing/0001493152-24-039111.json","markdown":"https://secwatch.observer/filing/0001493152-24-039111.md","text":"https://secwatch.observer/filing/0001493152-24-039111.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000149315224039111/0001493152-24-039111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000149315224039111/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T22:41:46.870204+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}